Home Cart Sign in  
Chemical Structure| 2079896-25-4 Chemical Structure| 2079896-25-4

Structure of GSK 4027
CAS No.: 2079896-25-4

Chemical Structure| 2079896-25-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GSK 4027 is a chemical probe for the PCAF/GCN5 bromodomain with an pIC50 of 7.4±0.11 for PCAF in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.

Synonyms: GSK 4027

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GSK 4027

CAS No. :2079896-25-4
Formula : C17H21BrN4O
M.W : 377.28
SMILES Code : O=C1C(Br)=C(N[C@H]2CN(C)C[C@@H](C3=CC=CC=C3)C2)C=NN1C
Synonyms :
GSK 4027
MDL No. :MFCD31735697

Safety of GSK 4027

Related Pathways of GSK 4027

epigenetics

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00175565 Chronic Obstructive Pulmonary ... More >>Disease Emphysema Chronic Bronchitis Less << Phase 4 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2R7 Canada, British Columbia University of British Columbia Vancouver, British Columbia, Canada, V6Z 1Y7 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.65mL

0.53mL

0.27mL

13.25mL

2.65mL

1.33mL

26.51mL

5.30mL

2.65mL

 

Historical Records

Categories